Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Post-Transplant Events

Respiratory status deterioration during G-CSF-induced neutropenia recovery

Summary:

Exacerbation of prior pulmonary involvement may occur during neutropenia recovery. Granulocyte colony-stimulating factor (G-CSF)-related pulmonary toxicity has been documented in cancer patients, and experimental models suggest a role for G-CSF in acute lung injury during neutropenia recovery. We reviewed 20 cases of noncardiac acute respiratory failure during G-CSF-induced neutropenia recovery. Half the patients had received hematopoietic stem cell transplants. All patients experienced pulmonary infiltrates during neutropenia followed by respiratory status deterioration coinciding with neutropenia recovery. Neutropenia duration was 10 (4–22) days, and time between respiratory symptoms and the first day with more than 1000 leukocytes/mm3 was 1 (−0.5 to 2) day. Of the 20 patients, 16 received invasive or noninvasive mechanical ventilation, including 14 patients with acute respiratory distress syndrome (ARDS). Five patients died, with refractory ARDS. In patients with pulmonary infiltrates during neutropenia, G-CSF-induced neutropenia recovery carries a risk of respiratory status deterioration with acute lung injury or ARDS. Clinicians must maintain a high index of suspicion for this diagnosis, which requires eliminating another cause of acute respiratory failure, G-CSF discontinuation and ICU transfer for early supportive management including diagnostic confirmation and noninvasive mechanical ventilation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Kress JP, Christenson J, Pohlman AS et al. Outcomes of critically ill cancer patients in a University Hospital Setting. Am J Respir Crit Care Med 1999; 160: 1957–1961.

    Article  CAS  Google Scholar 

  2. Ewig S, Torres A, Riquelme R et al. Pulmonary complications in patients with hematological malignancies treated at a respiratory ICU. Eur Respir J 1998; 12: 116–122.

    Article  CAS  Google Scholar 

  3. Blot F, Guiguet M, Nitenberg G et al. Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 1997; 33: 1031–1037.

    Article  CAS  Google Scholar 

  4. Azoulay E, Recher C, Alberti C et al. B. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 199; 25: 1395–1401.

    Article  Google Scholar 

  5. Azoulay E, Thiéry G, Chevret S et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine 2004; 83: 1–11.

    Article  Google Scholar 

  6. Hilbert G, Gruson D, Vargas F et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481–487.

    Article  CAS  Google Scholar 

  7. Azoulay E, Alberti C, Bornstain C et al. Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519–525.

    Article  CAS  Google Scholar 

  8. Cordonnier C, Fleury-Feith J, Escudier E et al. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994; 149: 788–794.

    Article  CAS  Google Scholar 

  9. Azoulay E, Fieux F, Moreau D et al. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003; 167: 1329–1333.

    Article  Google Scholar 

  10. Rinaldo JE, Borovetz H . Deterioration of oxygenation and abnormal lung microvascular permeability during resolution of leukopenia in patients with diffuse lung injury. Am Rev Respir Dis 1985; 131: 579–583.

    CAS  PubMed  Google Scholar 

  11. Azoulay E, Darmon M, Delclaux C et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 2002; 30: 781–786.

    Article  Google Scholar 

  12. Lieschke GJ, Burgess AW . Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med 1992; 327: 28–35.

    Article  CAS  Google Scholar 

  13. Lieschke GJ, Burgess AW . Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N Engl J Med 1992; 327: 99–106.

    Article  CAS  Google Scholar 

  14. Pfreundschuh M, Trümper L, Kloess M et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. Blood 2004; 104: 626–633.

    Article  CAS  Google Scholar 

  15. Pfreundschuh M, Trümper L, Kloess M et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 2004; 104: 634–641.

    Article  CAS  Google Scholar 

  16. Azoulay E, Attalah H, Harf A et al. Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Chest 2001; 120: 1695–1701.

    Article  CAS  Google Scholar 

  17. Takatsuka H, Takemoto Y, Mori A et al. Common features in the onset of ARDS after administration of granulocyte colony-stimulating factor. Chest 2002; 121: 1716–1720.

    Article  Google Scholar 

  18. Azoulay E, Attalah H, Yang K et al. Exacerbation with granulocyte colony-stimulating factor of prior acute lung injury during neutropenia recovery in rats. Crit Care Med 2003; 31: 157–165.

    Article  CAS  Google Scholar 

  19. Le Gall JR, Lemeshow S, Saulnier F . A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study [published erratum appears in JAMA 1994 May 4; 271(17): 1321]. JAMA 1993; 270: 2957–2963.

    Article  CAS  Google Scholar 

  20. Le Gall JR, Klar J, Lemeshow S et al. The logistic organ dysfunction system, a new way to assess organ dysfunction in the intensive care unit. JAMA 1996; 276: 802–810.

    Article  CAS  Google Scholar 

  21. Bernard GR, Artigas A, Brigham KL et al. The American–European Consensus Conference on ARDS: définitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149: 818–824.

    Article  CAS  Google Scholar 

  22. Wilczynski SW, Erasmus JJ, Petros WP et al. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med 1998; 157: 565–573.

    Article  CAS  Google Scholar 

  23. Glauser FL, Fairman RP . The uncertain role of the neutrophil increased permeability pulmonary edema. Chest 1985; 88: 601–607.

    Article  CAS  Google Scholar 

  24. Tate RM, Repine JE . Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983; 128: 552–559.

    Article  CAS  Google Scholar 

  25. Maunder RJ, Hackman RC, Riff E et al. Occurence of the adult respiratory distress syndrome in neutropenic patients. Am Rev Respir Dis 1986; 133: 313–316.

    CAS  PubMed  Google Scholar 

  26. Ognibene FP, Martin SE, Parker MM et al. Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 1986; 315: 547–551.

    Article  CAS  Google Scholar 

  27. King J, Deboisblanc BP, Mason CM et al. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat. Am J Respir Crit Care Med 151; 302: 1995.

    Google Scholar 

  28. Azoulay E, Herigault S, Levame M et al. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis. Crit Care Med 2003; 31: 1442–1448.

    Article  CAS  Google Scholar 

  29. Aggarwal A, Baker CS, Evans TW, Haslam PL . G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 2000; 15: 895–901.

    Article  CAS  Google Scholar 

  30. Wiedermann FJ, Mayr AJ, Hobisch-Hagen P et al. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. J Interferon Cytokine Res 2003; 23: 729–736.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank A Wolfe MD for helping with this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to É Azoulay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karlin, L., Darmon, M., Thiéry, G. et al. Respiratory status deterioration during G-CSF-induced neutropenia recovery. Bone Marrow Transplant 36, 245–250 (2005). https://doi.org/10.1038/sj.bmt.1705037

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705037

Keywords

This article is cited by

Search

Quick links